tiprankstipranks
Trending News
More News >
Bluebird bio Inc (BLUE)
NASDAQ:BLUE

Bluebird Bio (BLUE) Stock Statistics & Valuation Metrics

Compare
2,842 Followers

Total Valuation

Bluebird Bio has a market cap or net worth of $48.67M. The enterprise value is $85.38M.
Market Cap$48.67M
Enterprise Value$85.38M

Share Statistics

Bluebird Bio has 55,331,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding55,331,000
Owned by Insiders9.50%
Owned by Institutions13.80%

Financial Efficiency

Bluebird Bio’s return on equity (ROE) is 7.63 and return on invested capital (ROIC) is -82.57%.
Return on Equity (ROE)7.63
Return on Assets (ROA)-0.52
Return on Invested Capital (ROIC)-82.57%
Return on Capital Employed (ROCE)-1.95
Revenue Per Employee337.93K
Profits Per Employee-970.63K
Employee Count248
Asset Turnover0.18
Inventory Turnover1.37

Valuation Ratios

The current PE Ratio of Bluebird Bio is -0.34. Bluebird Bio’s PEG ratio is <0.01.
PE Ratio-0.34
PS Ratio0.00
PB Ratio-0.84
Price to Fair Value-2.56
Price to FCF-0.21
Price to Operating Cash Flow-0.21
PEG Ratio<0.01

Income Statement

In the last 12 months, Bluebird Bio had revenue of 83.81M and earned -240.72M in profits. Earnings per share was -24.84.
Revenue83.81M
Gross Profit-5.57M
Operating Income-270.46M
Pretax Income-240.65M
Net Income-240.72M
EBITDA-156.82M
Earnings Per Share (EPS)-24.84

Cash Flow

In the last 12 months, operating cash flow was -228.79M and capital expenditures -1.68M, giving a free cash flow of -230.47M billion.
Operating Cash Flow-228.79M
Free Cash Flow-230.47M
Free Cash Flow per Share-4.17

Dividends & Yields

Bluebird Bio pays an annual dividend of $177.66, resulting in a dividend yield of ―
Dividend Per Share$177.66
Dividend Yield
Payout RatioN/A
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta1.01
52-Week Price Change-75.15%
50-Day Moving Average
200-Day Moving Average
Relative Strength Index (RSI)
Average Volume (3m)

Important Dates

Bluebird Bio upcoming earnings date is Aug 12, 2025, Before Open (Confirmed).
Last Earnings DateMay 7, 2025
Next Earnings DateAug 12, 2025
Ex-Dividend DateNov 05, 2021

Financial Position

Bluebird Bio as a current ratio of 0.48, with Debt / Equity ratio of -199.53%
Current Ratio0.48
Quick Ratio0.28
Debt to Market Cap0.88
Net Debt to EBITDA-1.89
Interest Coverage Ratio-11.98

Taxes

In the past 12 months, Bluebird Bio has paid 70.00K in taxes.
Income Tax70.00K
Effective Tax Rate>-0.01

Enterprise Valuation

Bluebird Bio EV to EBITDA ratio is -2.40, with an EV/FCF ratio of -1.43.
EV to Sales4.50
EV to EBITDA-2.40
EV to Free Cash Flow-1.43
EV to Operating Cash Flow-1.45

Balance Sheet

Bluebird Bio has $78.74M in cash and marketable securities with $115.46M in debt, giving a net cash position of $36.71M billion.
Cash & Marketable Securities$78.74M
Total Debt$115.46M
Net Cash$36.71M
Net Cash Per Share$0.66
Tangible Book Value Per Share-$4.82

Margins

Gross margin is 27.12%, with operating margin of -322.72%, and net profit margin of -287.23%.
Gross Margin27.12%
Operating Margin-322.72%
Pretax Margin-287.14%
Net Profit Margin-287.23%
EBITDA Margin-187.12%
EBIT Margin-260.20%

Analyst Forecast

The average price target for Bluebird Bio is $8.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$8.00
Price Target Upside60.97% Upside
Analyst ConsensusModerate Buy
Analyst Count1
Revenue Growth Forecast127.51%
EPS Growth Forecast56.94%

Scores

Smart Score2
AI Score51
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis